Interaction between akt1-positive neurons and age at surgery is associated with surgical outcome in children with isolated focal cortical dysplasia

Journal of Neuropathology and Experimental Neurology

Volumn 72, Issue 9, 2013, Pages 884-891

  Miles, Lili ^a   Greiner, Hansel M ^b   Miles, Michael V ^a,b   Mangano, Francesco T ^c   Horn, Paul S ^b   Leach, James L ^e   Seo, Joo H ^d   Lee, Ki H ^c,e  

^a Department of Pediatrics   (United States)

^b Divisions of Pediatric Neurology   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d UNIVERSITY OF CINCINNATI   (United States)

^e FLORIDA HOSPITAL   (United States)

Author keywords

Akt1; Children; Epilepsy surgery; Focal cortical dysplasia; Outcome; Pathology

Indexed keywords

AKT1 PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTOSIS; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CORTICAL DYSPLASIA; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; EPILEPSY; FEMALE; GLIOSIS; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; ISOLATED FOCAL CORTICAL DYSPLASIA; MALE; MOLECULAR INTERACTION; NERVE CELL; NEUROIMAGING; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SEIZURE; TREATMENT OUTCOME;

ADOLESCENT; AGING; BRAIN DISEASES; CELL COUNT; CEREBRAL CORTEX; CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; MALFORMATIONS OF CORTICAL DEVELOPMENT; NEURONS; POSITRON-EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATIONS; PROTO-ONCOGENE PROTEINS C-AKT; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 84883597947     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3182a38d88     Document Type: Article

References (36)

1. Zupanc ML, Rubio EJ, Werner RR, et al. Epilepsy surgery outcomes: Quality of life and seizure control. Pediatr Neurol 2010;42:12-20
2. Russo E, Citraro R, Constanti A, et al. The mTOR signaling pathway in the brain: Focus on epilepsy and epileptogenesis. Mol Neurobiol 2012;46: 662-81
3. Baybis M, Yu J, Lee A, et al. mTOR cascade activation distinguishes tubers from focal cortical dysplasia. Ann Neurol 2004;56:478-87
4. Huang J, Manning BD. The TSC1-TSC2 complex: A molecular switchboard controlling cell growth. Biochem J 2008;412:179-90
5. Zeng LH, McDaniel S, Rensing NR, et al. Regulation of cell death and epileptogenesis by the mammalian target of rapamycin (mTOR): A double-edged sword? Cell Cycle 2010;9:2281-85
6. McDaniel SS, Wong M. Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis. Neurosci Lett 2011; 497:231-39
7. Ljungberg MC, Bhattacharjee MB, Lu Y, et al. Activation of mammalian target of rapamycin in cytomegalic neurons of human cortical dysplasia. Ann Neurol 2006;60:420-29
8. Cohen-Gadol AA, Ozduman K, Bronen RA, et al. Long-term outcome after epilepsy surgery for focal cortical dysplasia. J Neurosurg 2004;101:55-65
9. Hamiwka L, Jayakar P, Resnick T, et al. Surgery for epilepsy due to cortical malformations: Ten-year follow-up. Epilepsia 2005;46:556-60
10. Mathern GW. Challenges in the surgical treatment of epilepsy patients with cortical dysplasia. Epilepsia 2009;50(Suppl 9):45-50
11. Rowland NC, Englot DJ, Cage TA, et al. A meta-analysis of predictors of seizure-freedom in the surgical management of focal cortical dysplasia. J Neurosurg 2012;116:1035-41
12. Terra-Bustamante VC, Fernandes RM, Inuzuka LM, et al. Surgically amenable epilepsies in children and adolescents: Clinical, imaging, electrophysiological, and post-surgical outcome data. Childs Nerv Syst 2005; 21:546-51
13. Wang VY, Chang EF, Barbaro NM. Focal cortical dysplasia: A review of pathological features, genetics, and surgical outcome. Neurosurg Focus 2006;20:E7
14. Wyllie E, Comair YG, Kotagal P, et al. Epilepsy surgery in infants. Epilepsia 1996;37:625-37
15. Wyllie E, Comair YG, Kotagal P, et al. Seizure outcome after epilepsy surgery in children and adolescents. Ann Neurol 1998;44:740-48
16. Chang EF, Wang DD, Barkovich AJ. Predictors of seizure-freedom after surgery for malformations of cortical development. Ann Neurol 2011;70:151-62
17. Engel JJ, McDermott MP, Wiebe S, et al. Early surgical therapy for drug-resistant temporal lobe epilepsy: A randomized trial. JAMA 2012; 307:922-30
18. Kim YH, Kang HC, Kim DS, et al. Neuroimaging in identifying focal cortical dysplasia and prognostic factors in pediatric and adolescent epilepsy surgery. Epilepsia 2011;52:722-27
19. Seo JH, Holland K, Rose D, et al. Multimodality imaging in the surgical treatment of children with non-lesional epilepsy. Neurology 2011;76:41-48
20. Blümcke I, Thom M, Aronica E, et al. The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE DiagnosticMethods Commission. Epilepsia 2011;52:158-74
21. Wieser HG, BlumeWT, Fish D, et al. ILAE Commission Report. Proposal for a new classification of outcome with respect to epileptic seizures following epilepsy surgery. Epilepsia 2001;42:282-86
22. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: Wiley, 2000
23. Blümcke I, Mühlebner A. Neuropathological work-up of focal cortical dysplasias using the new ILAE consensus classification systemVPractical guideline article invited by the Euro-CNS Research Committee. Clin Neuropathol 2011;30:164-77
24. Han CW, Min BW, Kim Y, et al. Immunohistochemical analysis of developmental neural antigen expression in the balloon cells of focal cortical dysplasia. J Clin Neurosci 2011;18:114-18
25. Foresti ML, Arisi GM, Shapiro LA. Role of glia in epilepsy-associated neuropathology, neuroinflammation and neurogenesis. Brain Res Rev 2011;66:115-22
26. Krsek P, Jahodova A, Maton B, et al. Low-grade focal cortical dysplasia is associated with prenatal and perinatal brain injury. Epilepsia 2010;51: 2440-48
27. Sisodiya SM, Fauser S, Cross JH, et al. Focal cortical dysplasia Type II: Biological features and clinical perspectives. Lancet Neurol 2009;8: 830-43
28. Sarnat HB, Flores-Sarnat L. Radial microcolumnar cortical architecture: Maturational arrest or cortical dysplasia? Pediatr Neurol 2013;48:259-70
29. Sakakibara T, Sukigara S, Saito T, et al. Delayed maturation and differentiation of neurons in focal cortical dysplasia with the transmantle sign: Analysis of layer-specific marker expression. J Neuropathol Exp Neurol 2012;71:741-49
30. Foster KG, Fingar DC. Mammalian target of rapamycin (mTOR): Conducting the cellular signaling symphony. J Biol Chem 2010;285: 14071-77
31. Wong M. Mammalian target of rapamycin (mTOR) activation in focal cortical dysplasia and related focal cortical malformations. Exp Neurol 2013;244:22-26
32. Krsek P, Pieper T, Karlmeier A, et al. Different presurgical characteristics and seizure outcomes in children with focal cortical dysplasia Type I or II. Epilepsia 2009;50:125-37
33. Widdess-Walsh P, Kellinghaus C, Jeha L, et al. Electro-clinical and imaging characteristics of focal cortical dysplasia: Correlation with pathological subtypes. Epilepsy Res 2005;67:25-33
34. Lerner JT, Salamon N, Hauptman JS, et al. Assessment and surgical outcomes for mild type I and severe type II cortical dysplasia: A critical review and the UCLA experience. Epilepsia 2009;50:1310-35
35. Jimenez-Mateos EM, Henshall DC. Epilepsy and microRNA. Neuroscience 2013;238:218-29
36. Hauptman JS, Mathern GW. Surgical treatment of epilepsy associated with cortical dysplasia: 2012 update. Epilepsia 2012;53(Suppl 4):98-104